Cancer Treatment Research in Georgia
Cancer Treatment Research (93.395) awarded $104 million to recipients in Georgia in 96 grants from fiscal 2021 to 2025, 1.9% of the program's national total. Emory University received the most, $53.2 million.
- Awarded in Georgia$104 million
- Awards96
- Share of the program1.9%
- Rank among states16th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 39 | $16.5 million |
| FY 2022 | 46 | $21.8 million |
| FY 2023 | 49 | $22.9 million |
| FY 2024 | 47 | $22.4 million |
| FY 2025 | 42 | $20.0 million |
Recipients in Georgia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Emory University | Colleges and universities | 54 | $53.2 million |
| Georgia Tech Research Corp | Colleges and universities | 9 | $12.3 million |
| Augusta University Research Institute, Inc | Nonprofits | 9 | $11.7 million |
| Proda Biotech L.L.C. | Small businesses | 2 | $6.0 million |
| University of Georgia Research Foundation, Inc. | Colleges and universities | 3 | $4.0 million |
| Metaclipse Therapeutics Corp | Small businesses | 1 | $2.1 million |
| Oncospherix Inc | Small businesses | 1 | $2.0 million |
| Metcure Therapeutics LLC | Small businesses | 1 | $1.9 million |
| Cambium Oncology LLC | Small businesses | 2 | $1.8 million |
| Migra-Therapeutics, LLC | Small businesses | 1 | $1.8 million |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to Georgia?
$104 million from fiscal 2021 to 2025, across 96 awards. Georgia ranks 16th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in Georgia?
The largest recipient is Emory University, with $53.2 million in 54 awards. Next are Georgia Tech Research Corp and Augusta University Research Institute, Inc.
Can organizations in Georgia apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in Georgia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- 1332 State Innovation Waivers
- Children's Health Insurance Program
- Special Education Grants to States
- Temporary Assistance for Needy Families